Promoting effects of heparin on ex vivo expansion of megakaryocytopoiesis from human cord blood CD34+ cells

Transfusion Medicine and Hemotherapy

Volumn 40, Issue 5, 2013, Pages 344-350

  Maurer, Anne Marie ^a   Gezer, Altay ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

CD34+ cells; Cord blood; Expansion; Glycosaminoglycan; Megakaryocytopoiesis

Indexed keywords

FLT3 LIGAND; HEPARIN; INTERLEUKIN 11; INTERLEUKIN 6; STEM CELL FACTOR; THROMBOPOIETIN; COLLAGEN;

ARTICLE; BLOOD CELL; CD34+ CELL; CD41+ CELL; COLONY FORMING UNIT MEGAKARYOCYTE; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; THROMBOCYTE; UMBILICAL CORD BLOOD; COLONY FORMING UNIT;

EID: 84886613692     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000355519     Document Type: Article

References (35)

1. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD: Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988;71: 723-727.
2. Williams SF, Bitran JD, Richards JM, de Christopher PJ, Barker E, Conant J, Golomb HM, Orlina AR: Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Bone Marrow Transplant 1990;5: 129-133.
3. Wagner JE, Gluckman E: Umbilical cord blood transplantation: the first 20 years. Semin Hematol 2010;47: 3-12.
4. Rubistein PC, Carrier A, Scaradavou A, Krutzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfeld RE, Stevens CE: Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339: 1565-1577.
5. Kogler G, Nurnberger W, Fisher J, Niehues T, Somville T, Gobel U, Wernet P: Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia. Bone Marrow Transplant 1999: 24: 397-403.
6. Pecora AL, Stiff P, Jennis A, Goldberg S, Rosenbluth R, Price P, Goltry KL, Douville J, Armstrong RD, Smith AK, Preti RA: Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000;25: 797-799.
7. Schpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, Bearman SI, Nieto Y, Freed B, Madinger N, Hogan CJ, Slat-Vasquez V, Russell P, Blunk B, Schissel D, Hild E, Malcolm J, WardW, McNiece IK: Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002; 8: 368-376.
8. Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, Howrey R, Chao N, Douville J, Burhop S, Fu P, Kurtzberg J: Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells of a phase I trial using the AastroReplicell System. Blood 2003;101: 5061-5067.
9. de Lima M, Mcmannis J, Gee A, Komanduri K, Couriel D, Andersson BS, Hosing C, Khoury I, Jones R, Champlin R, Karandish S, Sadeghi T, Peled T, Grynspan F, Daniely Y, Nagler A, Shpall EJ: Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant 2008;41: 771-778.
10. Maurer AM, Liu Y, Caen JP, Han ZC: Ex vivo expansion of megakaryocytic cells. Int J Hematol 2000;71: 203-210.
11. Reems JA, Pineault N, Sun S: In vitro megakaryocyte production and platelet biogenesis: state of the art. Transfus Med Rev 2010;24: 33-43.
12. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, Oles KJ, Hultgren B, Solberg LA, Goeddel DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369: 533-538.
13. Kaushansky K: Thrombopoietin: a tool for understanding thrombopoiesis. J Thromb Haemost 2003; 7: 1587-1592.
14. Kaushansky K: Determinants of platelet number and regulation of thrombopoiesis. Hematology Am Soc Hematol Educ Program 2009;147-152.
15. Williams JL, Pipia GG, Datta NS, Long MW: Thrombopoietin requires additional megakaryocyte- active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood 1998;91: 4118-4126.
16. Lazzari L, Henschler R, Lecchi L, Rebulla P, Mertelsmann R, Sirchia G: Interleukin-6 and interleukin- act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells. Haematologica 2000;85: 25-30.
17. Li K, Yang M, Lam AC, Yau FW, Yuen PM: Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors. Cell Transplant 2000;9: 125-131.
18. Won JH, Cho SD, Park SK, Lee GT, Baick SH, Suh WS, Hong DS, Park HS: Thrombopoietin is synergistic with other cytokines for expansion of cord blood progenitor cells. J Hematother Stem Cell Res 2000;9: 465-473.
19. Klein G: The extracellular matrix of the hematopoietic microenvironment. Experentia 1995;51: 914-926.
20. Esko JD, Kimata K, Lindhal U: Proteoglycans and sulfated glycosaminoglycans; in: Varki A, RD Cummings, JD Esko, HH Freeze, P Stanley, CR Bertozzi, GW Hartand, ME Etzler (ed): Essentials of Glycobiology, 2nd ed. New York, Cold Spring Harbor Laboratory Press, 2009, pp 229-248.
21. Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM: Heparan sulfate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 1988;332: 376-378.
22. Gordon MY, Riley GP, Watt SM, Greaves MF: Compartimentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987;326: 403-405.
23. Gordon MY, Riley GP, Clarke D: Heparan sulfate is necessary for adhesive interactions between human early hemopoietic progenitors cells and the extracellular matrix of the bone marrow microenvironment. Leukemia 1988;2: 804-809.
24. Siczkowski M, Clarke D, Gordon MY: Binding of primitive hematopoietic progenitors cells to marrow stromal cells involves heparan sulfate. Blood 1992;80: 912-919.
25. Bruno E, Luikart SD, Long MW, Hoffman R: Marrow derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Exp Hematol 1995;23: 1212-1217.
26. Gupta P, Oegema TR Jr, Brazil JJ, Dudek AZ, Slungaard A, Verfaillie CM: Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood 1998;92: 4641-4651.
27. Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC: Heparin structure and interactions with basic fibroblast growth factor. Science 1996;271: 1116-1120.
28. Han ZC, Bellucci S, Shen ZX, Maffrand JP, Pascal M, Petitou M, Lormeau J, Caen JP: Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators. J Cell Physiol 1996;168: 97-104.
29. Shen ZX, Basara N, Xi XD, Caen JP, Maffrand JP, Pascal M, Petitou M, Lormeau JC, Han ZC: Fraxiparin, a low-molecular-weight heparin, stimulates megakaryopoiesis in vitro and in vivo in mice. Br J Haematol 1994;88: 608-612.
30. Han ZC, Sensebe L, Abgrall JF, Briere J: Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood 1990;75: 1234-1239.
31. Mathur A, Hong Y, Wang G, Erusalimsky JD: Assays of megakaryocyte development, surface antigen expression, ploidy, and size. Methods Mol Biol 2004;272: 309-322.
32. Kashiwakura I, Teramachi T, Kakizaki I, Takagi Y, Takahashi TA, Takagaki K: The effects of glycosaminoglycans on thrombopoietin-induced megakaryocytopoiesis. Haematologica 2006;91: 1-9.
33. Feng Y, Zhang L, Xiao ZJ, Li B, Liu B, Fan CG, Yuan XF, Han ZC: An effective and simple expansion system for megakaryocyte progenitor cells using a combination of heparin with thrombopoietin and interleukin-11. Exp Hematol 2005;33: 1537-1543.
34. Kishore V, Eliason JF, Matthew HWT: Covalently immobilized glycosaminoglycans enhance megakaryocyte progenitor expansion and platelet release. J Biomed Mater Res Part A 2011;96A: 682-692.
35. Levine RF, Shoff P, Han ZC, Eldor A: Circulating megakaryocytes and platelet production in the lungs. Prog Clin Biol Res 1990;356: 41-52.